By Stephen Nakrosis
Shares of Bioventus were up shortly before the market’s close on Thursday, following news board member John Bartholdson recently purchased shares of the company’s stock.
At 3:27 p.m. ET, the stock had risen 7.9%, to $3.56 a share. Volume at the time topped 824,000 shares, above the stock’s 65-day average volume of 762,427 shares.
After the bell Wednesday, the company reported Bartholdson had recently purchased 455,725 shares at $2.94 each. His holdings total over 6.3 million shares.
Bioventus has a market cap of $258.3 million, 62.49 million shares outstanding and a public float of 33.22 million. Year to date, the stock is up almost 40%.
Bioventus said it market products which “address a growing need for clinically effective, cost efficient, minimally invasive medical treatments, that engage and enhance the body’s natural healing processes.”
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
Read the full article here